Sinopep's Jiande and Lianyungang Sites Earn EcoVadis Bronze Medal Certification

HANGZHOU, China - Rezul -- Sinopep is proud to announce that its Jiande and Lianyungang facilities have successfully passed the rigorous sustainability assessment conducted by EcoVadis, a globally recognized leader in corporate sustainability ratings. Both sites were awarded the Bronze Medal, underscoring the company's continued commitment to environmental stewardship, human rights, ethical business practices, and responsible sourcing.

Press Release URL: https://sinopep.com/sinopeps-jiande-and-lianyungang-sites-earn-ecovadis-bronze-medal-certification/

A Global Benchmark in Sustainability
EcoVadis evaluates companies across four key pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. Its comprehensive framework provides credible benchmarks for sustainability performance across global supply chains. The Bronze Medal reflects not only Sinopep's compliance with international standards, but also its proactive efforts in embedding ESG (Environmental, Social, and Governance) principles into its operations.

More on Rezul News

• Keebos Launches Crossbody Cases for Every iPhone 17 Model
• West Virginia Biker Chick Elevates Service with Stretgic Partnership with Local Law Firm
• WOA Crypto redefines cloud Bitcoin mining, offering free access and instant profit opportunities
• Pepperdine University Malibu, California and Community Partners Recognized with 2025 ReadyCommunities Partnership National Service Award
• NBA Overachievers: OddsTrader Reveals Which Teams Will Exceed Expectations in 2025-26

Comprehensive Evaluation, Consistent Excellence
Sinopep's performance in the EcoVadis assessment was distinguished by its systematic and science-based approach to sustainability. Key highlights from the evaluation include:

Environmental Stewardship
Sinopep has built a robust environmental management system that spans its full production cycle. By investing in green technologies and promoting resource and energy recycling, the company continually reduces its environmental footprint while supporting long-term ecological sustainability.

Labor & Human Rights
Recognizing that people are central to sustainable success, Sinopep is committed to providing a fair, inclusive, and safe workplace. The company strictly prohibits forced labor and discrimination and has implemented comprehensive health and safety systems to protect and empower its workforce.

Ethical Governance
Integrity and transparency are foundational to Sinopep's operations. The company upholds high standards of business ethics and fair competition, while actively aligning with global initiatives such as the United Nations Global Compact to ensure responsible corporate governance.

Driving the Future of Sustainable Growth

More on Rezul News

• Crypto Betting Odds 2025: Bookmakers Review Analyzes Market Predictions and Year-End Price Lines
• The OpenSSL Corporation and the OpenSSL Foundation Celebrate the Success of the Inaugural OpenSSL Conference in Prague
• TKL Group's New Factory Commences Production, Pioneering A New Era In Global Heavy Duty Truck Parts
• Regulated Crypto Exchange TZNXG Addresses Core US Market Challenges with Compliance-First Infrastructure
• GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience

The Bronze Medal certification is a significant milestone in Sinopep's sustainability journey and a recognition of its progress in building a resilient and responsible business. Moving forward, Sinopep will continue to champion green innovation, deepen its ESG practices, and collaborate with global partners to shape a more sustainable future in the life and health industry.

About Sinopep
Sinopep (688076.SH) is a leading, technology-driven company specializing in the development and manufacturing of peptides, oligonucleotides, small molecule intermediates, APIs, and drug products. With nearly 15 years of diverse and extensive industry experience, we have consistently delivered high-quality products and services to global pharmaceutical and biotechnology companies, supporting their projects from preclinical development through to commercial production. Sinopep operates three R&D centers and two manufacturing facilities, all of which adhere to rigorous global quality and EHS standards and are approved by the US FDA and EDOM.

Author Contact Information:
email: chrisgothard@sinopep.com
website: https://sinopep.com/